Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity
Abstract Morphological characteristics and source of adipose tissue as well as adipokines may increase cardiometabolic risk. This study aimed to explore whether adipose tissue characteristics may impact metabolic and atherogenic risks. Subcutaneous Adipose Tissue (SAT), Visceral Adipose Tissue (VAT)...
Guardado en:
Ejemplares similares
-
Association of serum retinol binding protein 4 with atherogenic dyslipidemia in morbid obese patients.
por: Milagros Rocha, et al.
Publicado: (2013) -
Emerging Strategies for the Management of Atherogenic Dyslipidaemia
por: Anandita Agarwala, et al.
Publicado: (2020) -
New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
por: Alberto J Lorenzatti, et al.
Publicado: (2020) -
Hibernating brown bears are protected against atherogenic dyslipidemia
por: Sylvain Giroud, et al.
Publicado: (2021) -
Pathophysiological rationale for the results of atherogenic dyslipidemia simulation in rats
por: V. G. Banzaraksheev
Publicado: (2016)